Helena Brett-Smith's Colleagues at Trevi Therapeutics
Helena Brett-Smith's Contact Details
HQ
203-304-2499
203-304-2499
Location
Wallingford, Connecticut
Wallingford, Connecticut
Company
Trevi Therapeutics
Trevi Therapeutics
Helena Brett-Smith's Company Details
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Trevi is conducting a Phase 2b/3 clinical trial of Haduvio for the treatment of chronic pruritus associated with prurigo nodularis (PN) and a Phase 2 trial for chronic cough in patients with idiopathic pulmonary fibrosis (IPF). These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems, and both are areas of high unmet need. Founded in 2011, Trevi is headquartered in New Haven, CT.
Frequently Asked Questions about Helena Brett-Smith
Helena Brett-Smith currently works for Trevi Therapeutics.
Helena Brett-Smith's role at Trevi Therapeutics is Chief Development Officer.
Helena Brett-Smith's email address is ***@trevitherapeutics.com. To view Helena Brett-Smith's full email address, please signup to ConnectPlex.
Helena Brett-Smith works in the BioTech/Drugs industry.
Helena Brett-Smith's colleagues at Trevi Therapeutics are Kevin Fitzmaurice, Lisa Delfini, Dawn Newmin, Katie McManus, Lauren Waggoner Kriss, Lori Iwanicki, Lara Lewkowicz and others.
Helena Brett-Smith's phone number is 203-304-2499